Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Regularly reviewing your retirement plan is essential for long-term success. Find out when to make those important assessments.
20,077 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Southwest Airlines CEO Bob Jordan is taking a bold step to reclaim time for real work by blocking Wednesday through F...
AI growth stocks may ride the wave of innovation, but a stubborn helium shortage could cap upside. Even if Iran ends,...
Arm Holdings stunned markets with a powerful run, then pulled back after earnings. This guide breaks down whether thi...
After a steep slide, Novo Nordisk has shown fresh momentum. But can the rebound sustain, or is it just a temporary bo...
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
A pawn shop stock has surged 135% after a major fund disclosed a fresh $39 million stake. This article breaks down th...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
A consortium led by Barry Diller has proposed a $12.4 billion bid to take MGM Resorts private, a move that could resh...
As of June 2026, the U.S. has not approved a spot XRP ETF, while overseas markets offer XRP-linked funds. This comple...
Meta is weighing a large primary equity offering to fund an aggressive AI buildout as costs rise. Analysts warn dilut...
A Pennsylvania man lost $30,000 after a scammer claimed to be an FDIC courier. This guide breaks down the scam, flags...